Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.
Press releases published on October 2, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option
Offering was led by B Group Capital and Columbia Threadneedle Investments with significant participation from Adage Capital Partners LP, ADAR1 Capital Management, Boxer Capital Management, Coastlands Capital, Deep Track Capital, Janus Henderson Investors, …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
SEATTLE and VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of …
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US Operations at Novo Nordisk A/S and …
Midnight Sun Announces C$10 Million “Bought Deal” Life Offering and Private Placement of Units
/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Midnight Sun Mining Corp. (TSXV:MMA, OTC:MDNGF) (“Midnight Sun” or the “Company”) is …
National CACFP Association Welcomes Newly Elected Board Members
ROUND ROCK, TX, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- The National CACFP Association (NCA) is proud to announce the election of three distinguished professionals to its Board of Directors, each bringing decades of experience, dedication …
XS.com Nombra a Sharlini Vasuthevan como Country Manager para India
COLOMBIA, October 2, 2025 /Business News/ -- XS.com, el proveedor global de servicios financieros y FinTech galardonado, se complace en anunciar el nombramiento de Sharlini Vasuthevan como su nueva Country Manager para India. Este nombramiento refleja el …
XS.com Nomeia Sharlini Vasuthevan como Country Manager para a Índia
BRAZIL, October 2, 2025 /Business News/ -- XS.com, a premiada fornecedora global de FinTech e serviços financeiros, tem o prazer de anunciar a nomeação de Sharlini Vasuthevan como sua nova Country Manager para a Índia. Esta nomeação reflete o compromisso …
Caribbean Dream Home in Roatán With Charter Business Potential
JONESVILLE BIGHT, HONDURAS, October 1, 2025 /EINPresswire.com/ -- A waterfront property in Roatán’s Jonesville Bight has just hit the market. This turnkey waterfront home is located in the safe, calm waters of Jonesville Bight on Roatán’s East End—an …
CEO Kenneth W. Welch Jr. Invests Millions Supporting TikTok Independent Artists
La Fenetre Magazine Features Kenneth W. Welch Jr.'s Unprecedented Artist Support System Spanning Multiple Continents and Helping Launch Sustainable Careers LOS ANGELES, CA, UNITED STATES, October 1, 2025 /EINPresswire.com/ -- La Fenetre Magazine has …
A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform
TOKYO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (“A.D.A.M. Innovations”), Japan’s leading genomics and AI company, today announced the official launch of GeneLink, a breakthrough advertising platform that fuses genetics, lifestyle …
EVAA to Launch Token on Binance Alpha, MEXC, STON.fi, and Gate.io
Panama City, Panama, Oct. 02, 2025 (GLOBE NEWSWIRE) -- EVAA, a top lending protocol in the TON ecosystem, will host its Token Generation Event (TGE) on October 3, 2025, at tge.evaa.finance. On the same day, the $EVAA token will go live on multiple …
Collective Mining Increases Previously Announced Bought Deal Financing to C$125 Million
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Collective Mining Ltd. (NYSE: CNL, TSX: CNL) (“ …
Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting
Initial Phase 1 data suggest PRTH-101 contributes to disease control in recurrent/metastatic thymic epithelial carcinoma (TEC) with median progression-free survival (mPFS) of 7.9 months and 1 partial response (PR) observed Pivotal Phase 2 trial for the …
Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
FORT WORTH, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced that the …
Update on the General Meeting of Tethys Petroleum Limited
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Gazexport Limited (“Gazexport” or the “Company”) announces an update regarding changes to the Board of Directors of Tethys Petroleum Limited (“Tethys”). The Company considers the exclusion of its votes at the …
ESGold Secures C$9 Million Strategic Partnership with Ocean Partners as Montauban Progress Accelerates
Vancouver, BC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- via IBN -- ESGold Corp. (“ESGold” or the “Company”) (CSE: ESAU | OTCQB: ESAUF | FSE: Z7D) is pleased to announce it has entered into a binding term sheet with Ocean Partners UK Ltd. (“Ocean Partners”) for a …